Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Access expired on Saturday, August 19, 2017

This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.

Already Have An Account? Log in Now

Published in Oncology

Journal Scan / Research · July 13, 2017

Sequential Ipilimumab Monotherapy vs Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Efficacy of Sequential Ipilimumab Monotherapy vs Best Supportive Care For Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
Clin. Cancer Res 2017 Jun 27;[EPub Ahead of Print], YJ Bang, JY Cho, YH Kim, JW Kim, M Di Bartolomeo, JA Ajani, K Yamaguchi, A Balogh, T Sanchez, M Moehler

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading